Trials / Completed
CompletedNCT01098786
Drug Use Investigation for Cell-culture Derived Influenza A (H1N1) Emulsion HA Vaccine
Observational Study to Evaluate Safety of Cell-derived A/H1N1 Influenza HA Vaccine in Healthy Japanese Subjects
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 556 (actual)
- Sponsor
- Novartis Vaccines · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
This is to evaluate safety of cell-derived A/H1N1 influenza HA vaccine in healthy Japanese subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Cell-derived A/H1N1 influenza HA vaccine | Single group vaccinated |
Timeline
- Start date
- 2010-02-01
- Primary completion
- 2010-11-01
- Completion
- 2010-11-01
- First posted
- 2010-04-05
- Last updated
- 2017-03-14
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT01098786. Inclusion in this directory is not an endorsement.